Injection of blood cell components in knee joint for joint pain patients

Efficacy of intraarticular injection Of autologous platelet rich plasma in patients with knee osteoarthritis - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/068055

Enrollment

Registered

2024-05-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Injecting the platelet rich plasma in knee joint: 15-20 ml of blood withdrawn and prp is made and injected in to knee joint as regenerative therapy.this will be done once In a week for

Eligibility

Inclusion criteria

Inclusion criteria: Patient with knee joint swelling/pain for more than 3 months Xray showing degenerative changes

Exclusion criteria

Exclusion criteria: Patient refusal or not giving consent Infected knee joint /(Osteomyelitis) Hb Platelet Any Hematological disorders like CLL, ALL, AML Rheumatological disorders like RA, SLE Osteoarthritis grade I & IV

Design outcomes

Primary

Measure	Time frame
To assess the therapeutic effectiveness of PRP as a intraarticular injection to knee joint for OA patients by Womac scoringTimepoint: In 3 sitting of injection in gap of 1 week	—

Secondary

Measure	Time frame
Occurrence of side effects and complicationsTimepoint: In 3 sitting of injection in gap of 1 week	—

Countries

India

Contacts

Public ContactDr Jaideep singh

Gandhi medical college ,bhopal

drsurmi@rediffmail.com9862757745

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026